Table 3.

Enriched pathways of curcumin in the treatment on EC.

Term	ID	Input number	Background number	Corrected P value
Pathways in cancer	hsa05200	16	397	8.78E − 22
AGE-RAGE signaling pathway in diabetic complications	hsa04933	11	101	5.71E − 19
Hepatitis B	hsa05161	11	146	1.69E − 17
Colorectal cancer	hsa05210	9	62	1.44E − 16
Platinum drug resistance	hsa01524	8	75	6.38E − 14
Apoptosis	hsa04210	9	140	6.97E − 14
EGFR tyrosine kinase inhibitor resistance	hsa01521	8	81	1.07E − 13
Influenza A	hsa05164	9	176	4.20E − 13
Focal adhesion	hsa04510	9	203	1.22E − 12
Pancreatic cancer	hsa05212	7	66	2.78E − 12
Bladder cancer	hsa05219	6	41	2.52E − 11
Endocrine resistance	hsa01522	7	97	3.02E − 11
HIF-1 signaling pathway	hsa04066	7	103	4.35E − 11
PI3K-akt signaling pathway	hsa04151	9	342	8.19E − 11
Endometrial cancer	hsa05213	6	52	8.61E − 11